Clinical innovation
Practitioner-restricted medicines and professional treatment portfolios.
01Curated portfolio
We represent a deliberately limited group of portfolios across two distinct distribution channels.
Practitioner-restricted medicines and professional treatment portfolios.
01Devices and systems intended for appropriately qualified professional use.
02Clinically positioned supplementation supported through approved professional accounts.
03Distinctive presentation-led products for considered guest and client environments.
04Design-conscious ranges for selected optical practices and frame destinations.
05Access to Novatheris, Injevia and SYNERA is considered only for medical doctors or dentists with current HPCSA registration, subject to account approval and applicable order requirements.
Fonteira and Dani D may be considered for aligned professional, hospitality, salon, retail, optical and business environments. HPCSA registration is not required for this channel.
A note on access
Public pages introduce the distribution house; approved accounts receive the detail relevant to their channel.
Prescription-only products are not offered for public purchase or promoted as consumer products on this website. Product availability, pricing, documentation, professional-use requirements and delivery arrangements are confirmed directly with eligible account holders.
Choose an application